Abstract Despite affecting~ 11–13% of women globally, polycystic ovary syndrome (PCOS)
is a substantially understudied condition. PCOS, possibly extending to men's health …

Polycystic ovary syndrome (PCOS) affects about 12% of women of reproductive age. In
2018, the first evidence‐based guideline on assessment and management of PCOS was …

Metformin is a synthetic biguanide used as an antidiabetic drug in type 2 diabetes mellitus,
achieved by studying the bioactive metabolites of Galega officinalis L. It is also used off-label …

Metformin is best known as a foundational therapy for type 2 diabetes but is also used in
other contexts in clinical medicine with a number of emerging and potential indications …

Background Polycystic ovary syndrome (PCOS) is a heterogenous endocrine condition and
combined oral contraceptives (COCs) have been demonstrated to be the first-line treatment …

De Zegher and Ibanez suggest that metformin should be first-line treatment with the addition
of combined oral contraceptive pills (COCPs) if needed for adolescents with polycystic ovary …

Objective To study the combined and isolated effects of melatonin and metformin in the
ovarian tissue of rats with PCOS. Design Experimental study using a rat model of PCOS …

Isntroduction. Polycystic ovary syndrome (PCOS) is a multifaceted endocrine-gynecological
condition affecting a substantial number of women during their reproductive years …

In einer doppelblinden, randomisierten, placebokontrollierten Phase-2-Studie führte der GIP-
(glukoseabhängiges insulinotropes Peptid), GLP-1-(glukagonähnliches [„glucagon-like “] …

Background. Combined oral contraceptives (COCs) are of rst line treatment of women with
polycystic ovary syndrome (PCOS) who do not intend to become pregnant. PCOS is a …